Trinity Biotech (TRIB) vs Vivos Therapeutics (VVOS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Trinity Biotech is the larger company by market cap ($5.4 million vs $5.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | TRIB | VVOS |
|---|---|---|
| Share price | $6.70 | $0.1493 |
| Market cap | $5.45M | $5.02M |
| 1-day change | +10.93% | -0.13% |
| EPS (TTM) | $-60.00 | $-1.88 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $52.50 | $3.28 |
| 52-week low | $5.01 | $0.129 |
| Distance from 52-week high | -87.24% | -95.45% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +1319.96% |
| Average volume | 21.66K | 12.57M |
| Shares outstanding | 813.13K | 33.61M |
| Employees | 287 | 268 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Trinity Biotech
TRIB stock →Trinity Biotech plc, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Asia, Africa, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases, such as syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic measurement of haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 287 employees
About Vivos Therapeutics
VVOS stock →Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults.
Health Care · Medical/Dental Instruments · 268 employees
TRIB vs VVOS FAQ
Which is bigger, Trinity Biotech or Vivos Therapeutics?
Trinity Biotech (TRIB) is larger, with a market capitalization of $5.45M compared with $5.02M for Vivos Therapeutics (VVOS).
Are Trinity Biotech and Vivos Therapeutics in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: In Vitro & In Vivo Diagnostic Substances for Trinity Biotech and Medical/Dental Instruments for Vivos Therapeutics.